Form 4: Crexendo CSO Sells $579K in Pre-Scheduled Stock Sales

Crexendo's Chief Strategy Officer, Anand Buch, reported the sale of 88,000 shares of common stock across three pre-scheduled transactions in March 2026.

Summary

• Anand Buch, Chief Strategy Officer of Crexendo, Inc. (CXDO), reported the sale of 88,000 shares of common stock.
• The sales occurred over three separate transactions on March 11, 2026, and March 13, 2026.
• On March 11, 2026, 40,000 shares were sold at a price of $6.735 per share.
• On March 13, 2026, two transactions occurred: 28,000 shares were sold at $6.35 per share, and an additional 20,000 shares were sold at $6.60 per share.
• The total value of the shares sold across these transactions amounts to approximately $579,200.
• Following these transactions, Anand Buch beneficially owns 447,498 shares of Crexendo common stock.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly negative signal. While significant insider selling can raise concerns, the execution under a Rule 10b5-1 plan suggests the sales were pre-scheduled, potentially for personal financial planning rather than a reaction to new company developments.

Negatives

• Significant insider selling by a Chief Strategy Officer could be perceived negatively by the market, potentially signaling a lack of confidence in the company's near-term prospects, despite being pre-scheduled.

Industry Context

StockSavvy.ai notes that insider selling, even when pre-scheduled under a Rule 10b5-1 plan, is often scrutinized by investors. While such plans are designed to allow insiders to diversify holdings without being accused of trading on material non-public information, significant sales by a key executive like a Chief Strategy Officer can still be interpreted as a signal regarding the company's future prospects or valuation, potentially influencing market sentiment.

Stakeholder Impact

• Shareholders may perceive the insider selling as a negative signal, potentially impacting investor confidence and the company's stock price, despite the transactions being pre-scheduled under a 10b5-1 plan.

Key Dates

Recommendation

The sale of shares by a Chief Strategy Officer is generally viewed as a negative signal. However, the transactions were executed under a Rule 10b5-1 plan, indicating they were pre-scheduled and not necessarily based on recent non-public information. This mitigates some of the negative sentiment, leading to a 'hold' recommendation. Investors should monitor future insider activity and company performance closely for further indications.

Keywords

Crexendo, CXDO, Insider Trading, Stock Sale, Form 4, Anand Buch, Chief Strategy Officer, Rule 10b5-1